Organic Letters
Letter
2008, 14, 5737. (h) Olson, A. C.; Overman, L. E.; Sneddon, H. F.; Ziller,
J. W. Adv. Synth. Catal. 2009, 351, 3186. (i) Trost, B. M.; Toste, F. D. J.
Am. Chem. Soc. 1998, 120, 815. (j) Austeri, M.; Linder, D.; Lacour, J.
Adv. Synth. Catal. 2010, 352, 3339. (k) Trost, B. M.; Gunzner, J. L.;
Dirat, O.; Rhee, Y. H. J. Am. Chem. Soc. 2002, 124, 10396. (l) Trost, B.
M.; Crawley, M. L. J. Am. Chem. Soc. 2002, 124, 9328.
(5) To the best of our knowledge, there is only one known example of
the asymmetric synthesis of tertiary allylic aryl ethers through phenol
nucleophilic substitution. However, this protocol has quite limited
scope, see ref 2a. Controlling the regioselectivity in allylic substitution
with phenols is challenging, see: (a) Goux, C.; Massacret, M.; Lhoste, P.;
Sinou, D. Organometallics 1995, 14, 4585. (b) Trost, B. M.; Toste, F. D.
J. Am. Chem. Soc. 1999, 121, 4545.
(6) For asymmetric synthesis of allylic tertiary alkyl ethers through
allylic substitution with alcohol nucleophiles: (a) Trost, B. M.;
McEachern, E. J.; Toste, F. D. J. Am. Chem. Soc. 1998, 120, 12702.
(b) Trost, B. M.; Brown, B. S.; McEachern, E. J.; Kuhn, O. Chem. - Eur. J.
2003, 9, 4442. (c) Khan, A.; Khan, S.; Khan, I.; Zhao, C.; Mao, Y.; Chen,
Y.; Zhang, Y. J. J. Am. Chem. Soc. 2017, 139, 10733.
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge on the
■
S
Experimental details and spectra for new products (PDF)
Accession Codes
CCDC 1585738 contains the supplementary crystallographic
data for this paper. These data can be obtained free of charge via
Crystallographic Data Centre, 12 Union Road, Cambridge
CB2 1EZ, UK; fax: +44 1223 336033.
AUTHOR INFORMATION
■
Corresponding Author
ORCID
(7) Continuous endeavors have been devoted to develop new methods
for the asymmetric synthesis of tertiary aryl ethers, please see, for
example: (a) Forbeck, E. M.; Evans, C. D.; Gilleran, J. A.; Li, P.; Joullie,
́
Author Contributions
‡These authors contributed equally to this work.
Notes
M. M. J. Am. Chem. Soc. 2007, 129, 14463. (b) Woiwode, T. F.; Rose, C.;
Wandless, T. J. J. Org. Chem. 1998, 63, 9594. (c) Shibatomi, K.;
Kotozaki, M.; Sasaki, N.; Fujisawa, I.; Iwasa, S. Chem. - Eur. J. 2015, 21,
́
14095. (d) Li, P.; Forbeck, E. M.; Evans, C. D.; Joullie, M. M. Org. Lett.
2006, 8, 5105. (e) Woiwode, T. F.; Rose, C.; Wandless, T. J. J. Org.
Chem. 1998, 63, 9594.
(8) For seminal work using vinyl cyclic carbonates in synthetic
chemistry: Bando, T.; Harayama, H.; Fukazawa, Y.; Shiro, M.; Fugami,
K.; Tanaka, S.; Tamaru, Y. J. Org. Chem. 1994, 59, 1465.
(9) Selected recent examples including contributions from our
research group: (a) Guo, W.; Martínez-Rodríguez, L.; Kuniyil, R.;
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
We thank the Cerca program/Generalitat de Catalunya, ICREA,
and the Spanish Ministerio de Economıa y Competitividad
■
́
Martin, E.; Escudero-Adan
Soc. 2016, 138, 11970. (b) Guo, W.; Martínez-Rodríguez, L.; Martín, E.;
Escudero-Adan, E. C.; Kleij, A. W. Angew. Chem., Int. Ed. 2016, 55,
́
, E. C.; Maseras, F.; Kleij, A. W. J. Am. Chem.
(MINECO) through projects CTQ-2014-60419-R, and the
Severo Ochoa Excellence Accreditation 2014−2018 through
project SEV-2013-0319. We acknowledge the analytical
assistance (HPLC) from the CTAE unit from ICIQ. J.X. thanks
the CSC (2016-06200061) for a predoctoral fellowship.
́
11037. (c) Khan, A.; Zheng, R.; Kan, Y.; Ye, J.; Xing, J.; Zhang, Y. J.
Angew. Chem., Int. Ed. 2014, 53, 6439. (d) Ohmatsu, K.; Imagawa, N.;
Ooi, T. Nat. Chem. 2014, 6, 47. (e) Wang, H.; Lorion, M. M.;
Ackermann, L. ACS Catal. 2017, 7, 3430. (f) Gom
́
ez, J. E.; Guo, W.;
Kleij, A. W. Org. Lett. 2016, 18, 6042.
REFERENCES
■
(10) Cai, A.; Guo, W.; Martínez-Rodríguez, L.; Kleij, A. W. J. Am.
Chem. Soc. 2016, 138, 14194.
(11) (a) Kumar, N.; Leray, I.; Depauw, A. Coord. Chem. Rev. 2016, 310,
1. (b) Awual, M. R.; Yaita, T.; Miyazaki, Y.; Matsumura, D.; Shiwaku, H.;
Taguchi, T. Sci. Rep. 2016, 6, 19937.
(1) For the total synthesis of Ustiloxin D using an allylic tertiary aryl
ether as intermediate: Sawayama, A. M.; Tanaka, H.; Wandless, T. J. J.
Org. Chem. 2004, 69, 8810.
(2) (a) Trost, B. M.; Toste, F. D. J. Am. Chem. Soc. 1998, 120, 9074.
(b) Trost, B. M.; Shen, H. C.; Dong, L.; Surivet, J.-P.; Sylvain, C. J. Am.
Chem. Soc. 2004, 126, 11966. (c) Trost, B. M.; Shen, H. C.; Dong, L.;
Surivet, J.-P. J. Am. Chem. Soc. 2003, 125, 9276. (d) Trost, B. M.;
Asakawa, N. Synthesis 1999, 1999, 1491. (e) Trost, B. M. J. Org. Chem.
2004, 69, 5813.
(3) Enantioenriched derivatives of tertiary (allylic) aryl ethers are
frequently encountered in pharmaceuticals or used as important
building blocks in synthesis, see: (a) Trost, B. M.; Crawley, M. L.
Chem. Rev. 2003, 103, 2921. Original contributions: (b) Cao, B.; Park,
(12) Hydrogen bond assistance should also be considered, please refer
to ref 9a and ref 10.
(13) Alkali metal cations have strong affinity for oxygen donors, see for
example ref 11.
(14) Enantioenriched chromanes are important fragments in many
drugs and natural products such as vitamin E, Clusifoliol, Siccanin, and
Calanolide A; see ref 2.
(15) The S-containing substrates have the potential to poison the Pd-
catalyst and typically require higher reaction temperatures, see ref 9f.
(16) Enantioenriched compounds with 1,3-benzodioxole fragments
are of interest in pharmaceutical development: Bloom, J. D.; Dutia, M.
D.; Johnson, B. D.; Wissner, A.; Burns, M. G.; Largis, E. E.; Dolan, J. A.;
Claus, T. H. J. Med. Chem. 1992, 35, 3081.
́
H.; Joullie, M. M. J. Am. Chem. Soc. 2002, 124, 520. (c) Tanaka, H.;
Sawayama, A. M.; Wandless, T. J. J. Am. Chem. Soc. 2003, 125, 6864.
(d) Mizuguchi, E.; Achiwa, K. Chem. Pharm. Bull. 1997, 45, 1209.
(e) Pochetti, G.; Mitro, N.; Lavecchia, A.; Gilardi, F.; Besker, N.; Scotti,
E.; Aschi, M.; Re, N.; Fracchiolla, G.; Laghezza, A.; Tortorella, P.;
Montanari, R.; Novellino, E.; Mazza, F.; Crestani, M.; Loiodice, F. J.
Med. Chem. 2010, 53, 4354.
(17) In the presence of L12, the likely formation of the more
nucleophilic CsOPh species further facilitates catalytic turnover.
(4) For the asymmetric synthesis of secondary allylic aryl ethers and
related chemistry, see, for example: (a) Trost, B. M.; Toste, F. D. J. Am.
Chem. Soc. 2000, 122, 11262. (b) Trost, B. M.; Tang, W. J. Am. Chem.
Soc. 2002, 124, 14542. (c) Onitsuka, K.; Okuda, H.; Sasai, H. Adv. Synth.
Catal. 2008, 47, 1454. (d) Kirsch, S. F.; Overman, L. E.; White, N. S. Org.
Lett. 2007, 9, 911. (e) Kim, D.; Reddy, S.; Singh, O. V.; Lee, J. S.; Kong,
S. B.; Han, H. Org. Lett. 2013, 15, 512. (f) Trivedi, R.; Tunge, J. A. Org.
Lett. 2009, 11, 5650. (g) Austeri, M.; Linder, D.; Lacour, J. Chem. - Eur. J.
D
Org. Lett. XXXX, XXX, XXX−XXX